- Home
- FOLD vs BKU Comparison
FOLD vs BKU Comparison
Compare FOLD & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- BKU
- Stock Information
- Founded
- FOLD 2002
- BKU 2009
- Country
- FOLD United States
- BKU United States
- Employees
- FOLD N/A
- BKU N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- BKU Savings Institutions
- Sector
- FOLD Health Care
- BKU Finance
- Exchange
- FOLD Nasdaq
- BKU Nasdaq
- Market Cap
- FOLD 2.9B
- BKU 2.9B
- IPO Year
- FOLD 2007
- BKU 2011
- Fundamental
- Price
- FOLD $6.32
- BKU $35.73
- Analyst Decision
- FOLD Strong Buy
- BKU Hold
- Analyst Count
- FOLD 10
- BKU 10
- Target Price
- FOLD $26.89
- BKU $41.60
- AVG Volume (30 Days)
- FOLD 4.2M
- BKU 847.9K
- Earning Date
- FOLD 07-31-2025
- BKU 07-23-2025
- Dividend Yield
- FOLD N/A
- BKU 3.47%
- EPS Growth
- FOLD N/A
- BKU 51.05
- EPS
- FOLD N/A
- BKU 3.41
- Revenue
- FOLD $571,160,000.00
- BKU $999,760,000.00
- Revenue This Year
- FOLD $19.97
- BKU $13.53
- Revenue Next Year
- FOLD $22.92
- BKU $7.08
- P/E Ratio
- FOLD N/A
- BKU $10.50
- Revenue Growth
- FOLD 32.29
- BKU 13.39
- 52 Week Low
- FOLD $5.51
- BKU $28.21
- 52 Week High
- FOLD $12.65
- BKU $44.45
- Technical
- Relative Strength Index (RSI)
- FOLD 55.44
- BKU 41.09
- Support Level
- FOLD $6.06
- BKU $37.59
- Resistance Level
- FOLD $6.40
- BKU $38.50
- Average True Range (ATR)
- FOLD 0.28
- BKU 1.04
- MACD
- FOLD 0.01
- BKU -0.36
- Stochastic Oscillator
- FOLD 49.44
- BKU 19.46
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.